Knoll Capital Management, LLC Diversified Active

CIK: 0001325083 · Show all filings

Period: Q3 2015 (← Previous) (Next →)

Filing Date: Nov 16, 2015

Total Value ($000): $235,563 (100.0% shares, 0.0% debt)

Holdings (19)

— Medivation, Inc. 79.3%

Value ($000) $186,908 Shares 4,397,838 Est. Cost $45.85 Unrealized —

— Ampio Pharmaceuticals Inc. 4.2%

Value ($000) $9,792 Shares 3,388,322 Est. Cost $6.03 Unrealized —

— Synthetic Biologics Inc. 3.6%

Value ($000) $8,477 Shares 3,734,149 Est. Cost $1.55 Unrealized —

— Alcobra Ltd 2.9%

Value ($000) $6,737 Shares 1,115,315 Est. Cost $7.08 Unrealized —

— Abeona Therapeutics Inc 2.3%

Value ($000) $5,507 Shares 1,359,767 Est. Cost $5.06 Unrealized —

— Corbus Pharmaceuticals HLDGS 1.8%

Value ($000) $4,325 Shares 2,750,000 Est. Cost $2.53 Unrealized —

— Newlink Genetics Corp 1.6%

Value ($000) $3,671 Shares 102,437 Est. Cost $27.98 Unrealized —

— Advaxis Inc. 1.2%

Value ($000) $2,813 Shares 275,000 Est. Cost $20.33 Unrealized —

— Bio Blast Pharma Ltd 0.7%

Value ($000) $1,721 Shares 338,110 Est. Cost $7.27 Unrealized —

— Caladrius Biosciences Inc 0.6%

Value ($000) $1,490 Shares 1,000,000 Est. Cost $1.87 Unrealized —

ALDX Aldeyra Therapeutics Inc 0.3%

Value ($000) $792 Shares 135,800 Est. Cost $10.20 Unrealized -23.5%

— Advaxis Inc. 0.3%

Value ($000) $731 Shares 112,500 Est. Cost $15.55 Unrealized —

— Keryx Biopharmaceuticals Inc. 0.3%

Value ($000) $704 Shares 200,000 Est. Cost $10.21 Unrealized —

— OHR Pharmaceutical Inc 0.2%

Value ($000) $566 Shares 205,000 Est. Cost $2.54 Unrealized —

— Lion Biotechnologies Inc 0.2%

Value ($000) $559 Shares 97,100 Est. Cost $12.11 Unrealized —

— Galmed Pharmaceuticals Ltd 0.2%

Value ($000) $483 Shares 65,000 Est. Cost $11.48 Unrealized —

— Evoke Pharma Inc 0.1%

Value ($000) $162 Shares 55,660 Est. Cost $7.00 Unrealized —

— Zosano Pharma Corp 0.0%

Value ($000) $74 Shares 18,600 Est. Cost $10.10 Unrealized —

— Aptose Biosciences Inc 0.0%

Value ($000) $51 Shares 11,933 Est. Cost $5.40 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Medivation, Inc.	4,397,838	$186,908	79.3%	$45.85	—	COM	58501N101
—	Ampio Pharmaceuticals Inc.	3,388,322	$9,792	4.2%	$6.03	—	COM	03209T109
—	Synthetic Biologics Inc.	3,734,149	$8,477	3.6%	$1.55	—	COM	87164U102
—	Alcobra Ltd	1,115,315	$6,737	2.9%	$7.08	—	SHS	M2239P109
—	Abeona Therapeutics Inc	1,359,767	$5,507	2.3%	$5.06	—	COM	00289Y107
—	Corbus Pharmaceuticals HLDGS	2,750,000	$4,325	1.8%	$2.53	—	COM	21833P103
—	Newlink Genetics Corp	102,437	$3,671	1.6%	$27.98	—	COM	651511107
—	Advaxis Inc.	275,000	$2,813	1.2%	$20.33	—	COM NEW	7624208
—	Bio Blast Pharma Ltd	338,110	$1,721	0.7%	$7.27	—	SHS	M20156101
—	Caladrius Biosciences Inc	1,000,000	$1,490	0.6%	$1.87	—	COM	128058104
ALDX	Aldeyra Therapeutics Inc	135,800	$792	0.3%	$10.20	-23.5%	COM	01438T106
—	Advaxis Inc.	112,500	$731	0.3%	$15.55	—	W EXP 07/15/201	7624117
—	Keryx Biopharmaceuticals Inc.	200,000	$704	0.3%	$10.21	—	COM	492515101
—	OHR Pharmaceutical Inc	205,000	$566	0.2%	$2.54	—	COM NEW	67778H200
—	Lion Biotechnologies Inc	97,100	$559	0.2%	$12.11	—	COM	53619R102
—	Galmed Pharmaceuticals Ltd	65,000	$483	0.2%	$11.48	—	SHS	M47238106
—	Evoke Pharma Inc	55,660	$162	0.1%	$7.00	—	COM	30049G104
—	Zosano Pharma Corp	18,600	$74	0.0%	$10.10	—	COM	98979H103
—	Aptose Biosciences Inc	11,933	$51	0.0%	$5.40	—	COM NEW	03835T200